title: Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
authors.forename: Melina
authors.initials: M
authors.lastname: Gattellari
authors.forename: Jeanette E
authors.initials: JE
authors.lastname: Ward
mesh_terms: D000728:Androgens / Q000172:deficiency; D002755:Choice Behavior; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011468:Prostatectomy / Q000009:adverse effects; D011471:Prostatic Neoplasms / Q000473:pathology / Q000503:physiopathology* / Q000523:psychology / Q000601:surgery*; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D012537:Scandinavian and Nordic Countries; D012725:Sexual Behavior
chemical_list: D000728:Androgens